Nebenwirkungen · Aldara
ALDARA 5% cream · Abschnitt 4.8 · PDF-Seite 10
HOS-088051 · Präparat HOS-083607
Investigators of the placebo controlled clinical trials were required to evaluate protocol mandated clinical signs (skin reactions). These protocol mandated clinical sign assessments indicate that severe erythema (31%) severe erosions (13%) and severe scabbing and crusting (19%) were very common in these trials with imiquimod cream applied 5 times weekly. Local skin reactions, such as erythema, are probably an extension of the pharmacologic effect of imiquimod cream.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-18T11:40:00Z · SHA-256 29a2c6949b9e74d0aba2dc8c33290a7bc20b103110a06b748f4e53afb53b0ce7 · Passage f16a41209cd3b593f3e20319fb49f370928caea8890874a31c9dc2dafcc7e033 · Zeichen 10828–11299 im Abschnitt